Related Experiment Videos
Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets--an obstetric emergency?
Insights
Severe preeclampsia with HELLP syndrome may not require immediate delivery. Management without prompt delivery improved maternal condition and resolved thrombocytopenia and elevated liver enzymes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Critical Care in Pregnancy
Background:
- Severe preeclampsia is a serious condition characterized by hypertension during pregnancy.
- HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is a severe variant of preeclampsia.
- Current management often involves prompt delivery, but its necessity in HELLP syndrome is debated.
Purpose of the Study:
- To evaluate the management and outcomes of severe preeclampsia with HELLP syndrome.
- To determine if immediate delivery is always warranted for patients with hemolysis, elevated liver enzymes, and thrombocytopenia.
- To assess the impact of conservative management on maternal and fetal outcomes.
Main Methods:
- Study included 27 patients with severe preeclampsia, hemolysis, elevated liver enzymes, and thrombocytopenia.
- Patients were managed with strict bed rest and magnesium sulfate to prevent seizures.
- Delivery was performed promptly only in cases of maternal or fetal deterioration or confirmed fetal lung maturity.
Main Results:
- Maternal condition improved within 72 hours of delivery in most cases.
- Thrombocytopenia and elevated liver enzymes resolved post-delivery.
- Delaying delivery until fetal lung maturity (L:S ratio) resulted in minimal respiratory distress syndrome (RDS).
Conclusions:
- Immediate delivery may not be necessary for all preeclamptic patients with HELLP syndrome.
- Conservative management with close monitoring can be effective.
- HELLP syndrome may represent a spectrum of hypertensive disorders in pregnancy rather than a distinct entity.
Abstract:
A study was undertaken of 27 patients with severe preeclampsia who had hemolysis, liver enzyme elevation, and thrombocytopenia as described by Weinstein. In addition to this triad, all patients exhibited the symptoms and signs of pregnancy-induced hypertension by which the diagnosis is usually established. These patients were admitted to the hospital for strict bed rest. Patients who showed evidence of rapid maternal or fetal deterioration were delivered promptly. The remainder were managed without immediate delivery and with the institution of magnesium sulfate to prevent eclamptic seizures. Patients were monitored closely, and amniocentesis was performed to ascertain fetal lung status. If the lungs were mature, the infant was delivered. Attempting to delay delivery until a lecithin: sphingomyelin (L:S) ratio was mature resulted in only two infants developing respiratory distress syndrome (RDS); both had L:S ratios of less than 1.5 and were delivered for maternal indications. Maternal condition rapidly improved within 72 hours of delivery, and there was no persistence of thrombocytopenia or elevation of liver enzymes. Immediate delivery of preeclamptic patients who have thrombocytopenia and elevated liver enzymes may not be warranted. These findings suggest that the syndrome of hemolysis, elevated liver enzymes, and low platelets is not a separate entity, but merely a cluster of signs seen in some patients with hypertensive disorders in pregnancy.